ACI in Forbes: FDA Action Can Save Lives, Money

Dr. Joseph Fuhr, Jr., professor of Economics and a senior fellow at ACI, wrote a piece on how biosimilar competition could provide wider choice and cheaper access to lifesaving drugs for patients, but the FDA needs to write the rules necessary to permit competitive entry.

His piece is available to read and print at Forbes.

FacebooktwitterredditlinkedinFacebooktwitterredditlinkedin